A Study of Nipocalimab in Children Aged 2 to less than 18 Years with Generalized Myasthenia Gravis
Last Updated   March 16, 2023 - 00:00
OVERVIEW
-
Gender
all -
Age
years -
Phase
phase 3The drug or treatment is given to large groups of people to confirm its effectiveness, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. -
Sites
sites -
Status
Recruiting
SUMMARY
The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (<) 18 years of age, the safety and tolerability of treatment with nipocalimab in children and adolescents and to evaluate the pharmacokinetics (PK) of nipocalimab in children and adolescents with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing, stable standard-of-care therapy.
CONDITIONS
- Myasthenia Gravis
ELIGIBILITY
Inclusion Criteria:
- • Diagnosis of myasthenia gravis (MG) with generalized muscle weakness meeting the clinical criteria for generalized myasthenia gravis (gMG) as defined by the Myasthenia Gravis Foundation of America (MGFA) Clinical Classification Class IIa/b, IIIa/b, or IVa/b at screening
- • Has a positive serologic test for acetylcholine receptor (anti-AChR) antibodies or muscle-specific tyrosine kinase (anti-MuSK) antibodies at screening
- • A participant using herbal, naturopathic, traditional Chinese remedies, ayurvedic or nutritional supplements, or medical marijuana (with a doctor’s prescription) is eligible if the use of these medications is acceptable to the Investigator. These remedies must remain at a stable dose and regimen throughout the study
- • Has sufficient venous access to allow drug administration by infusion and blood sampling as per the protocol
- • Participants should have a body weight and body mass index between 5th and 95th percentile for age and sex. Obese participants greater than 95th percentile and underweight participants below 5th percentile may participate following medical clearance
- • A female of childbearing potential must have a negative highly sensitive serum (beta-human chorionic gonadotropin [beta-hCG]) at Screening and a negative urine pregnancy test at Day 1 prior to administration of study intervention
Exclusion Criteria:
- • Has a history of severe and/or uncontrolled hepatic (example, viral/alcoholic/ autoimmune hepatitis/ cirrhosis/ and/or metabolic liver disease), gastrointestinal, renal, pulmonary, cardiovascular (including congenital heart diseases), psychiatric, neurological musculoskeletal disorder, any other medical disorder(s) (example, diabetes mellitus), or clinically significant abnormalities in screening laboratory, that might interfere with participant's full participation in the study, and/ or might jeopardize the safety of the participant or the validity of the study results
- • Has any confirmed or suspected clinical immunodeficiency syndrome not related to treatment of his/her generalized myasthenia gravis (gMG), or has a family history of congenital or hereditary immunodeficiency unless confirmed absent in the participant
- • Has had a thymectomy within 12 months prior to screening, or thymectomy is planned during the Active treatment Phase of the study
- • Has shown a previous severe immediate hypersensitivity reaction, such as anaphylaxis to therapeutic proteins (example, monoclonal antibodies)
- • Has experienced myocardial infarction, unstable ischemic heart disease, or stroke within 12 weeks of screening
DETAILS
LOCATIONS
Country (5) | City or Province (25) | Status |
United States | Ann Arbor, MI C.S. Mott Children’s Hospital |
Recruiting
|
United States | Aurora, CO Children’s Hospital Colorado |
Not yet recruiting
|
United States | Charleston, SC Medical University of South Carolina |
Not yet recruiting
|
United States | Dallas, TX Children's Health Specialty Center |
Withdrawn
|
United States | Hershey, PA Penn State Milton S. Hershey Medical Ctr. |
Not yet recruiting
|
United States | Lawrence, KS University of Kansas Medical Center |
Recruiting
|
United States | Los Angeles, CA Childrens Hospital Los Angeles |
Not yet recruiting
|
United States | Palo Alto, CA Lucile Packard Children's Hospital Stanford |
Recruiting
|
United States | Pasadena, CA Care Access Research |
Withdrawn
|
United States | Philadelphia, PA Childrens Hospital Of Philadelphia |
Not yet recruiting
|
United States | Phoenix, AZ Phoenix Children's Hospital |
Recruiting
|
United States | Pittsburgh, PA University of Pittsburgh Medical Center |
Not yet recruiting
|
United States | San Francisco, CA UCSF Benioff Children's Hospital |
Not yet recruiting
|
United States | Tampa, FL University of South Florida Morsani Center for Advanced Healthcare |
Recruiting
|
Poland | Gdansk Uniwersyteckie Centrum Kliniczne |
Not yet recruiting
|
Poland | Katowice NZOZ Wielospecjalistyczna Poradnia Lekarska 'Synapsis' |
Withdrawn
|
Netherlands | Leiden Leiden University Medical Center |
Recruiting
|
Japan | Azumino-shi, Nagano, 20 Nagano Children's Hospital |
Recruiting
|
Japan | Chiba Chiba University Hospital |
Recruiting
|
Japan | Miyazaki, 45 University of Miyazaki Hospital |
Recruiting
|
Japan | Saitama-shi, 11 Saitama Prefecture Children's Medical Center |
Recruiting
|
Japan | Shinjuku-ku, 13 Tokyo Women's Medical University Hospital |
Recruiting
|
Canada | London, ON Western University |
Withdrawn
|
Canada | Quebec, QC CHU de Québec Université Laval |
Withdrawn
|
Canada | Vancouver, BC British Columbia Children's Hospital |
Withdrawn
|
Indicates 50+ sites in this region: click to zoom in.
Indicates 10+ sites in this region: click to zoom in.
Indicates < 10 sites in this region: click to zoom in.
Corresponds to individual site.